Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Chembiochem : a European Journal of Chemical Biology
|
March 3, 2005
The target discovery process
Ursula Egner, Jörn Krätzschmar, Bertolt Kreft, et al.
Cellular Signalling
|
October 26, 2005
LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain
Daniel Korr, Luisella Toschi, Peter Donner, et al.
Breast Cancer Research and Treatment
|
March 14, 2013
Isogenic human mammary epithelial cell lines: novel tools for target identification and validation. Comprehensive characterization of an isogenic human mammary epithelial cell model provides evidence for epithelial-mesenchymal transition
Ulrike Ulbricht, Anette Sommer, Georg Beckmann, et al.
Molecular Human Reproduction
|
March 27, 2004
Cyr61, a deregulated gene in endometriosis
Yvonne Absenger, Holger Hess-Stumpp, Bertolt Kreft, et al.
Cancer Medicine
|
December 11, 2014
Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis
Julia C Meier, Bernard Haendler, Henrik Seidel, et al.
The Journal of Biological Chemistry
|
April 1, 2016
Functional and Structural Characterization of Bub3·BubR1 Interactions Required for Spindle Assembly Checkpoint Signaling in Human Cells
Florian Prinz, Vera Puetter, Simon J Holton, et al.
Molecular Cancer Therapeutics
|
April 10, 2014
Anetumab ravtansine: a novel mesothelin-targeting antibody-drug conjugate cures tumors with heterogeneous target expression favored by bystander effect
Sven Golfier, Charlotte Kopitz, Antje Kahnert, et al.
Journal of Medicinal Chemistry
|
September 27, 2024
Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against Cancer
Jeffrey Mowat, Rafael Carretero, Gabriele Leder, et al.
Cancer Immunology Research
|
April 22, 2020
Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2)
Julia Huetter, Uwe Gritzan, Ilona Gutcher, et al.
Molecular Cancer Therapeutics
|
February 3, 2016
Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity
Antje M Wengner, Gerhard Siemeister, Marcus Koppitz, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Chembiochem : a European Journal of Chemical Biology
|
March 3, 2005
The target discovery process
Ursula Egner, Jörn Krätzschmar, Bertolt Kreft, et al.
Cellular Signalling
|
October 26, 2005
LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain
Daniel Korr, Luisella Toschi, Peter Donner, et al.
Breast Cancer Research and Treatment
|
March 14, 2013
Isogenic human mammary epithelial cell lines: novel tools for target identification and validation. Comprehensive characterization of an isogenic human mammary epithelial cell model provides evidence for epithelial-mesenchymal transition
Ulrike Ulbricht, Anette Sommer, Georg Beckmann, et al.
Molecular Human Reproduction
|
March 27, 2004
Cyr61, a deregulated gene in endometriosis
Yvonne Absenger, Holger Hess-Stumpp, Bertolt Kreft, et al.
Cancer Medicine
|
December 11, 2014
Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis
Julia C Meier, Bernard Haendler, Henrik Seidel, et al.
The Journal of Biological Chemistry
|
April 1, 2016
Functional and Structural Characterization of Bub3·BubR1 Interactions Required for Spindle Assembly Checkpoint Signaling in Human Cells
Florian Prinz, Vera Puetter, Simon J Holton, et al.
Molecular Cancer Therapeutics
|
April 10, 2014
Anetumab ravtansine: a novel mesothelin-targeting antibody-drug conjugate cures tumors with heterogeneous target expression favored by bystander effect
Sven Golfier, Charlotte Kopitz, Antje Kahnert, et al.
Journal of Medicinal Chemistry
|
September 27, 2024
Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against Cancer
Jeffrey Mowat, Rafael Carretero, Gabriele Leder, et al.
Cancer Immunology Research
|
April 22, 2020
Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2)
Julia Huetter, Uwe Gritzan, Ilona Gutcher, et al.
Molecular Cancer Therapeutics
|
February 3, 2016
Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity
Antje M Wengner, Gerhard Siemeister, Marcus Koppitz, et al.
Page
of 2